Skip to main content
. 2025 Sep 9;15(9):594. doi: 10.3390/bios15090594
XDR Extensive drug-resistant
MDR Multidrug-resistant
BLAs β-lactam antibiotics
PBPs Penicillin-binding proteins
ESBLs Extended-spectrum β-lactamases
BLI β-lactamases inhibitor
BLA β-lactam antibiotic
MICs Minimum inhibitory concentrations
LB Luria–Bertani
RLU Relative light units
DDW Double-distilled water
IC50 50% inhibitory concentrations
PDA Potato Dextrose agar
GPY Glucose Peptone Yeast
ASW Artificial seawater
cUTI Complicated urinary tract
cIAI Complicated intra-abdominal infections
HAP Hospital-acquired pneumonia
VAP Ventilator-associated pneumonia
HTS High-throughput screening
NMR Nuclear magnetic resonance
FBDD Fragment-based drug discovery